SCHEMBL64926

SCHEMBL64926

c1cc2cnc[nH]c-2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30945055 0.98 CYP3A4 (0.42)
Hydrochloric Acid SCHEMBL310787 0.98 CYP3A4 (0.42)
Hydrochloric Acid SCHEMBL311521 0.98 CYP3A4 (0.42)
SCHEMBL7500298 0.98 CYP3A4 (0.42)
SCHEMBL15880175 0.92 CYP3A4 (0.39)
Formaldoxime SCHEMBL4910460 0.89 CYP3A4 (0.37)
Urea SCHEMBL15380857 0.89 ALDH1A1 (0.38)
Hexane SCHEMBL28298905 0.87 CYP2D6 (0.46)
Acetamide SCHEMBL9934071 0.86 CCNC (0.37)
SCHEMBL28294876 0.80 HRH3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4453 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3478295-B1 SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES PHARMACOSMOS HOLDING AS (DK) 2026-05-27 EP claimed
CN-122036736-A Pyrrolo [2,3-d ] pyrimidine derivative, synthetic method and application 云南大学 2026-05-15 CN claimed
EP-4363043-B1 COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS NOVOCURE GMBH (CH) 2026-04-22 EP claimed
WO-2025149628-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE ASTRAZENECA AB (SE) 2025-07-17 WO claimed
CN-119977970-A Luxolitic preparation method of nylon 雅本(绍兴)药业有限公司 2025-05-13 CN claimed
CN-117777136-B 1, 3-Disubstituted tetrahydropyrrole derivative and preparation method and application thereof 沈阳药科大学 2025-04-29 CN claimed
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 WO claimed
US-20250129429-A1 GENE FUSIONS IN SARCOMA FOUNDATION MEDICINE, INC. (US) 2025-04-24 US claimed
CN-119841843-A Compound combined with CRBN protein and degradation agent of CRBN protein 中国海洋大学 2025-04-18 CN claimed
CN-119613409-A Pyrrolo [2,3-d ] pyrimidine derivatives and their use in the preparation of anti-inflammatory agents 浙江工业大学 2025-03-14 CN claimed
EP-0673376-A1 NOVEL BICYCLIC PYRIMIDINE COMPOUNDS, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS. ADIR (FR) 1995-09-27 EP claimed
US-5349064-A Production of pyrrolopyrimidines TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-09-20 US claimed
WO-1994013668-A1 NOVEL BICYCLIC PYRIMIDINE COMPOUNDS, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS ADIR ET COMPAGNIE (FR) 1994-06-23 WO claimed
EP-0549886-A1 Process for the preparation of pyrrolo[2,3-d]pyrimidines THE TRUSTEES OF PRINCETON UNIVERSITY (US) 1993-07-07 EP claimed
EP-0514540-A1 PYRROLO 2,3-d]PYRIMIDINE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL PREPARATION COMPRISING THE DERIVATIVE AS ACTIVE INGREDIENT TEIJIN LIMITED (JP) 1992-11-25 EP claimed
WO-1992012718-A1 ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1992-08-06 WO claimed
EP-0496617-A1 Adenosine kinase inhibitors GENSIA, INC. (US) 1992-07-29 EP claimed
CN-1048705-A Process for preparing pyrrolopyrimidines and intermediates thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1991-01-23 CN claimed
EP-0402903-A1 Production of pyrrolopyrimidines and intermediates therefor Takeda Chemical Industries, Ltd. (JP) 1990-12-19 EP claimed
US-4028184-A CULTURING CORYNEBACTERIUM, ARTHROBACTER, MICROBACTERIUM KIKKOMAN SHOYU CO., LTD. (JA) 1977-06-07 US claimed